snsinsider 님의 블로그

The mRNA Technology Market was valued at USD 35.67 billion in 2023 and is projected to more than double, reaching USD 76.45 billion by 2032, with a strong CAGR of 8.88% over the forecast period from 2024 to 2032. The rapid expansion of mRNA-based therapeutics and vaccines, particularly driven by advancements in drug development, is significantly contributing to the market’s growth.Key Drivers of..

The Biologics Market was valued at USD 433.77 billion in 2023 and is projected to more than double, reaching USD 977.36 billion by 2032, expanding at a CAGR of 9.46% over the forecast period of 2024-2032. The market's rapid growth is fueled by the increasing prevalence of chronic diseases, advancements in biotechnology, and a rising demand for personalized medicine. Biologics, including monoclon..

The Cardiac Rhythm Management Devices Market was valued at USD 18.51 billion in 2023 and is projected to grow significantly, reaching USD 32.35 billion by 2032, at a CAGR of 6.40% during the forecast period from 2024 to 2032. The increasing prevalence of cardiovascular diseases, advancements in medical technology, and growing awareness regarding cardiac health are key factors driving market grow..

The Wearable Cardiac Devices Market was valued at USD 3.72 billion in 2023 and is expected to witness an extraordinary surge, reaching USD 25.71 billion by 2032, growing at a CAGR of 24.0% from 2024 to 2032. The rapid adoption of wearable technology in healthcare, combined with the increasing prevalence of cardiovascular diseases (CVDs), is driving market expansion. These devices offer real-time..